Pre-screening of endomysial microvessel density by fast random forest image processing machine learning algorithm accelerates recognition of a modified vascular network in idiopathic inflammatory myopathies.

Journal: Diagnostic pathology
PMID:

Abstract

Biomarkers for discrimination among different subgroups of idiopathic inflammatory myopathies (IIM) are difficult to identify and may involve multiple laboratory tests and time-consuming procedures. We assessed the potential for artificial intelligence (AI) to extract features such as density of endomysial microvessels based on automatic analysis of the CD31 vascular network on muscle biopsy images. We also assessed the potential of this technique to save time and its agreement rate with analyses based on the manual selection of microvessels from the same images. A total of 84 images from 84 patients with IIM, diagnosed between 2014 and 2020, were retrieved and analyzed using the Fast Random Forest (FRF) technique. We built a lightweight and explainable algorithm for calculating the pixel percentage of CD31 endomysial capillaries. The FRF technique applied on images of CD31-stained muscle sections achieved a good performance in the recognition of microvessels by estimating their density over a standard area corresponding to a sample of microscope image. The time spent for this analysis was 90% less than the manual choice of microvessels (estimated time considering the computational time and the time spent to manually detecting the microvessels features). The good performance of the FRF demonstrates that the CD31 pixel percentage of endomysial capillaries is sufficient for a correct estimation. Finally, the paper proposes a procedure to integrate AI in the pre-screening process.

Authors

  • Alessandro Massaro
    Università LUM "Giuseppe Degennaro", S.S. 100-km 18, Casamassima, 70010 Bari, Italy.
  • Gerardo Cazzato
    Dipartimento dell'Emergenza e dei Trapianti di Organi, Università degli Studi di Bari "Aldo Moro", Bari, Italy.
  • Giuseppe Ingravallo
    Section of Pathology, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari "Aldo Moro", 70124 Bari, Italy.
  • Nadia Casatta
    Innovation Department, Diapath S.p.A., Via Savoldini n.71, 24057 Martinengo, Italy.
  • Carmelo Lupo
    Innovation Department, Diapath S.p.A., Via Savoldini n.71, 24057 Martinengo, Italy.
  • Angelo Vacca
    Centro Interdisciplinare Ricerca Telemedicina-CITEL, Università degli Studi di Bari "Aldo Moro", 70124 Bari, Italy.
  • Florenzo Iannone
    Department of Precision and Regenerative Medicine and Ionian Area-Rheumatology Unit, University of Bari Aldo Moro, Bari, Italy.
  • Francesco Girolamo
    Unit of Human Anatomy and Histology, Department of Translational Biomedicine and Neuroscience "DiBraiN", University of Bari, Bari, Italy.